'Hated' CEO Lowering Price of $750 AIDS Drug DaraprimCNNSep. 23, 2015 |
Claim Jewish Student Was 'Stabbed In The Eye' by Pro-Palestine Protester Draws Mockery After Video Released
Mike Johnson Pushes Debunked Lie That Israeli Babies Were 'Cooked in Ovens' On October 7
'These Protesters Belong in Jail': Gov. Abbott Cheers Arrest of Pro-Palestine Protesters at UT Austin
'It Has to Be Stopped': Netanyahu Demands Pro-Palestine Protests at U.S. Colleges Be Shut Down
Senate Passes $95B Giveaway to Israel, Ukraine, and Taiwan, Combined With TikTok Ban
The company that hiked the price of Daraprim, a drug used to treat AIDS patients, is backing off. Pharmaceutical company Turing increased the price of a drug called Daraprim from $13.50 to $750 a pill and its CEO, Martin Shkreli, quickly became the focus of public anger. The over 4,000% increase also caught the eye of Hillary Clinton. She tweeted about it Monday, saying she wanted to put an end to drug "price gouging." Read More |